Lv61
1760 积分 2024-11-20 加入
Combination of CHK1 and CHK2 inhibitors exerts synergistic antitumor effects against neuroblastoma cells
6天前
已完结
Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor Combinations
22天前
已关闭
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency
29天前
已完结
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency
29天前
已关闭
Pregnancy outcomes in patients with vitiligo: A nationwide population-based cohort study from Korea
1个月前
已完结
Integrating homologous recombination deficiency and replication stress: converging strategies unlocking new frontiers in precision oncology
1个月前
已完结
Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiation
1个月前
已完结
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma
1个月前
已完结
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer
1个月前
已关闭
Targeting ATR in Cancer therapy: A drug discovery perspective
1个月前
已关闭
皖公网安备34019202002308
